The efficacy of non-surgical platelet-rich fibrin application on clinical periodontal parameters and periostin level in periodontitis: Clinical trial

Platelet-rich fibrin (PRF) has been widely used in regenerative dentistry due to many growth factors produced. Periostin, a matricellular protein, is a reliable marker for tissue regeneration. Periostin is part of the cellular matrix and regulates bone homeostasis. This study aims to explore the efficacy of PRF in improvement of the clinical periodontal parameters as an adjunct to the scaling and root planing and to evaluate periostin level in gingival crevicular fluid (GCF) at baseline, 1- and 3-month recall visits. Fourteen periodontitis patients who met the inclusion criteria were recruited in this study. Two contralateral periodontal pockets with 4-6 mm in depth in each patient were selected. The sites in every participant were randomly allocated into control sites or test sites. In control sites, only conventional scaling and root planing was carried out. In test sites, however, scaling and root planing method and PRF were applied. Periostin level in GCF and clinical periodontal parameters were measured. The test sites revealed greater relative attachment gain (2.614 +/- 0.606 mm and 3.321 +/- 0.668 mm) than control sites (1.285 +/- 0.671 mm and 1.839 +/- 0.632 mm) and a significant pocket reduction (2.535 +/- 0.664 mm and 3.321 +/- 0.668 mm) than the control sites (1.21 +/- 0.508 mm and 1.892 +/- 0.655 mm) at 1- and 3-month recall visits respectively. In the test sites, level of periostin (48.83 +/- 9.3 ng/mu l and 98.90 +/- 24.94 ng/mu l) were greater than periostin levels in the control sites (42.65 +/- 7.03 ng/mu l and 49.29 +/- 15.14 ng/mu l) at 1- and 3-month recall visits respectively. In conclusion, the non-surgical application of PRF as an adjunct to scaling and root planing significantly improved the clinical periodontal parameters through raising periostin level in GCF.